Protagonist Therapeutics Eulerpool naujienos

Protagonist Therapeutics Eulerpool News

Protagonist Therapeutics akcijų naujienos

Protagonist Therapeutics stebi daugybė žurnalistų ir investuotojų visame pasaulyje. Naujausias Protagonist Therapeutics naujienas mes pateikiame čia.

• birželio 17 d. ·

  TipRanks
  3 Best Stocks to Buy Now, 6/17/2024, According to Top Analysts
• birželio 16 d. ·

  TipRanks
  Analysts Are Bullish on These Healthcare Stocks: Syndax Pharmaceuticals (SNDX), Protagonist Therapeutics (PTGX)
• birželio 15 d. ·

  Yahoo
  We Think Some Shareholders May Hesitate To Increase Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) CEO Compensation
• birželio 14 d. ·

  TipRanks
  Buy Rating for Protagonist Therapeutics: Strong Clinical Results and Strategic Partnerships Drive Positive Outlook
• birželio 14 d. ·

  Yahoo
  Protagonist Reports Updated Long Term Results from Rusfertide Phase 2 REVIVE Study at the EHA2024 Congress Showing Durable Hematocrit Control
• birželio 14 d. ·

  TipRanks
  Positive Phase 3 Prospects for Protagonist Therapeutics’ Rusfertide: A Buy Rating Justified by REVIVE Trial Data
• birželio 9 d. ·

  Yahoo
  Has Protagonist Therapeutics, Inc.'s (NASDAQ:PTGX) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
• birželio 5 d. ·

  Yahoo
  The 3 Best Biotech Stocks to Buy in June 2024
• birželio 5 d. ·

  InvestorPlace
  The 3 Best Biotech Stocks to Buy in June 2024
• gegužės 31 d. ·

  Yahoo
  Protagonist Therapeutics to Participate in the Jefferies Global Healthcare Conference 2024